Performance. Defined.

InVitria Blog | Cell Culture and Biotech Manufacturing Insights

Jeanne McAdara Ph.D.

Jeanne McAdara Ph.D.
Dr. McAdara is part of InVitria's medical and scientific communications team. She has been involved in scientific communications for 19 years and is the Principal of Biolexica Health Science Communications. Dr. McAdara earned her Ph.D. in Macromolecular and Cellular Structure and Chemistry from The Scripps Research Institute and was a postdoctoral fellow in the Jonsson Comprehensive Cancer Center, where she studied the biochemical and cellular mechanisms underlying leukemia.
Find me on:

Recent Posts

Universal Vaccine Against Seasonal Influenza Steps Closer to Reality with the Results of FluGen Phase 2 Clinical Trial

Posted By Jeanne McAdara Ph.D. on 2/19/19 10:00 AM

On Tuesday, the vaccine company FluGen announced promising preliminary results from a placebo-controlled, Phase 2 clinical trial of their investigational intranasal influenza vaccine, M2SR, in 99 healthy adults challenged with the A/Belgium/4217/2015, H3N2 strain.

Read More

Subscribe to our Blog:

Follow InVitria: